Intervention
modafinil
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownModafinil Treatment for Sleep/Wake Disturbances in Older AdultsNCT00626210 · 2008-02-01
TERMINATEDModafinil Augmentation in Chronic Schizophrenia and Schizoaffective DisorderNCT00838227 · 2008-02-01
WITHDRAWNComparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's DiseaseNCT00393562 · 2006-03-01
WITHDRAWNModafinil for Treatment of Cognitive Dysfunction in SchizophreniaNCT00423943 · 2005-09-01
COMPLETEDModafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaNCT00314639 · 2005-09-01
COMPLETEDA Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With SchizophreniaNCT00573417 · 2003-09-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
WITHDRAWN2
TERMINATED1
Phase mix
PHASE43
PHASE22
NA1
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.